Caffeine has little to no benefit after 3 nights of sleep restriction
News Jun 14, 2016
New study shows caffeine is not sufficient to prevent performance decline long term -
A new study found that after restricting sleep to 5 hours per night, caffeine use no longer improved alertness or performance after three nights.
Results show that relative to placebo, caffeine significantly improved Psychomotor Vigilance Task (PVT) performance during the first 2 days, but not the last 3 days of sleep restriction.
"We were particularly surprised that the performance advantage conferred by two daily 200 mg doses of caffeine was lost after three nights of sleep restriction," said lead author Tracy Jill Doty, PhD, research scientist at Walter Reed Army Institute of Research. "These results are important, because caffeine is a stimulant widely used to counteract performance decline following periods of restricted sleep. The data from this study suggests that the same effective daily dose of caffeine is not sufficient to prevent performance decline over multiple days of restricted sleep."
The research abstract was published recently in an online supplement of the journal Sleep and was presented Monday, June 13 and Tuesday, June 14, in Denver at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
Don't Miss: Can Coffee Reduce the Risk of MS?
The study group consisted of 48 healthy individuals who participated in a double blind, placebo-controlled study. Sleep was restricted to five hours of time in bed for a total of five days. Participants were administered either 200 mg of caffeine or a placebo twice daily. A cognitive task battery was administered hourly during the wake periods and included a 10-minute PVT, Profile of Mood States (POMS), and the Stanford Sleepiness Scale (SSS). A modified Maintenance of Wakefulness Test (mMWT) was administered six times per day.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
SLEEP 2016 - 30th annual meeting of the Associated Professional Sleep Societies LLC
Abstract 0254: So CJ et al. Caffeine Efficacy Across a Simulated 5-day Work Week with Sleep Restriction.
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.
Researchers are One Step Closer to Developing Eye Drops to Treat Age-Related Macular DegenerationNews
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).READ MORE
A Bad Mood May Help Your Brain With Everyday TasksNews
New research found that being in a bad mood can help some people’s executive functioning, such as their ability to focus attention, manage time and prioritize tasks.READ MORE